Answers are grounded in this paper and cite their sources.
Dear Editor Liver tumours affecting the hepatocaval confluence may sometimes be resectable only by means of total vascular exclusion (TVE) of the liver and hypothermic perfusion. Ante situm surgery may be considered in selected patients whose tumours are otherwise unresectable. As such procedures are associated with a considerable risk of morbidity and mortality1,2, the adoption of hypothermic oxygenated machine perfusion (HOPE) may improve results. HOPE is known to improve hepatocellular energy status and organ viability after ischaemia–reperfusion injury3,4. In a first experience in humans, in vivo HOPE was employed during ante situm liver resection in five consecutive patients with critically located intrahepatic cholangiocarcinoma (Table S1 and Appendix 1). A machine perfusion system (LiverAssist, Organ Assist, Groningen, The Netherlands©) pumped the perfusate into an inflow cannula in the portal vein (Fig. 1). Perfusate was either recovered from an outflow cannula in a suprahepatic vein, or suctioned from the abdomen and filtered through a cell saver (Fresenius CATS©) before being returned to the device for chilling and oxygenation. The cannula length never exceeded 1.5 m to avoid increase in flow resistance. Celsior (IGL©) was used routinely both for static and HOPE organ preservation for transplantation (also because of the low potassium content), although several alternative preservation solutions exist (Table S2). Aggregated hypothermic oxygenated machine perfusion data a Flow, b pressure, c perfusate and liver surface temperature, and d surgical setting. Values are mean(s.d.). Aggregated hypothermic oxygenated machine perfusion data a Flow, b pressure, c perfusate and liver surface temperature, and d surgical setting. Values are mean(s.d.). Artery canulation was never performed to avoid vascular intimal injury and reconstruction-related complications. An extracorporeal venovenous bypass was set up with a Biopump© to maintain haemodynamic stability. Splanchnic congestion was reduced by use of an H-shaped portocaval shunt with an autologous graft (Fig. S1), or cannulation of the portal vein as part of the femorosubclavian bypass. After Glissonian pedicle clamping, the vena cava was clamped above the renal veins and at the diaphragmatic hiatus, and then interrupted in its cranial part. If the inferior vena cava (IVC) was found not to be infiltrated, the liver could be detached by interruption of the suprahepatic and short hepatic veins. The liver was then mobilized anteriorly in the ante situm position, remaining inside the abdomen and being connected by cannulas to the HOPE machine. A cavitron ultrasonic surgical aspirator was used for dissection, and vessels were divided between clips. IVC continuity was restored either by direct suture, reconstruction with a patch, or replacement with a prosthetic Dacron© tube. Hepatic veins could be reimplanted directly or by interposing a homologous graft. Procedural data are presented in Tables S1, S2, and Fig. 1. No postoperative liver failure or deaths were encountered, and liver function tests normalized within the first week (Appendix 4 and Fig. S2). In a historical cohort of nine ante situm resections performed with conventional hypothermic preservation, median survival was 22 months, and three patients survived more than 6 years. However, three patients with the longest ischaemia time developed severe postoperative liver insufficiency. The duration of TVE was longer than reported previously1 as both the transection and vascular reconstruction were performed during the cold phase to achieve better control. Operating times for complex operations can vary considerably and, in conditions of uncertain hypothermic protection, surgeons may be obliged to rush to avoid parenchymal injury. The efficacy of conventional cold flushing is questionable during prolonged in vivo TVE, and studies are lacking. Even in the HOPE–TVE setting, liver temperature was relatively high. However, HOPE may be associated with more efficient and widespread diffusion of cold perfusate and oxygen than cold flushing. For selected situations, ante situm resection with HOPE–TVE may extend the pathophysiological benefits seen in transplantation to the field of surgical oncology. Disclosure. The authors declare no conflict of interest. Supplementary material is available at BJS online.
No takes yet. Share an insight, caveat, or question.
Cillo et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: